Jo J - Search Results

1

c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value.

Molina R, Jo J, Filella X, Zanon G, Pahisa J, Mu noz M, Farrus B, Latre ML, Escriche C, Estape J, Ballesta AM. Molina R, et al. Among authors: jo j. Breast Cancer Res Treat. 1998 Sep;51(2):109-19. doi: 10.1023/a:1005734429304. Breast Cancer Res Treat. 1998. PMID: 9879773

2

Significance of CA72.4 in patients with colorectal cancer. Comparison with CEA and CA19.9.

Filella X, Molina R, Mengual PJ, Jo J, Ballesta AM. Filella X, et al. Among authors: jo j. J Nucl Biol Med (1991). 1991 Jul-Sep;35(3):158-61. J Nucl Biol Med (1991). 1991. PMID: 1816871

3

Clinical usefulness of CEA as tumor marker in patients with colorectal cancer.

Filella X, Molina R, Bedini JL, Jo J, Joseph J, Ballesta AM. Filella X, et al. Among authors: jo j. J Nucl Med Allied Sci. 1990 Oct-Dec;34(4 Suppl):107-10. J Nucl Med Allied Sci. 1990. PMID: 2092102 No abstract available.

4

CYFRA 21-1 in lung cancer: comparison with CEA, CA 125, SCC and NSE serum levels.

Molina R, Agusti C, Mañe JM, Filella X, Jo J, Joseph J, Giménez N, Estapé J, Ballesta AM. Molina R, et al. Among authors: jo j. Int J Biol Markers. 1994 Apr-Jun;9(2):96-101. doi: 10.1177/172460089400900206. Int J Biol Markers. 1994. PMID: 7523548 Clinical Trial.

5

Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients.

Molina R, Zanón G, Filella X, Moreno F, Jo J, Daniels M, Latre ML, Giménez N, Pahisa J, Velasco M, et al. Molina R, et al. Among authors: jo j. Breast Cancer Res Treat. 1995;36(1):41-8. doi: 10.1007/BF00690183. Breast Cancer Res Treat. 1995. PMID: 7579505 Clinical Trial.

6

Prognostic value of TPS in patients with head and neck malignancies: comparison with SCC.

Molina R, Torres MD, Moragas M, Filella X, Jo J, Giménez N, Traserra J, Ballesta AM. Molina R, et al. Among authors: jo j. Anticancer Res. 1995 Mar-Apr;15(2):479-84. Anticancer Res. 1995. PMID: 7763026

7

Carcinoembryonic antigen in staging and follow-up of patients with solid tumors.

Ballesta AM, Molina R, Filella X, Jo J, Giménez N. Ballesta AM, et al. Among authors: jo j. Tumour Biol. 1995;16(1):32-41. doi: 10.1159/000217926. Tumour Biol. 1995. PMID: 7863220 Review.

8

Mucin-like carcinoma-associated antigen (MCA) in tissue and serum of patients with breast cancer: clinical applications in prognosis and disease monitoring.

Molina R, Jo J, Filella X, Zanon G, Grau JJ, Joseph J, Bedini JL, Biete A, Ballesta AM. Molina R, et al. Among authors: jo j. Int J Biol Markers. 1993 Apr-Jun;8(2):113-23. doi: 10.1177/172460089300800208. Int J Biol Markers. 1993. PMID: 8366294

9

Prognostic significance of SCC antigen in the serum of patients with head and neck cancer.

Molina R, Torres MD, Moragas M, Perez-Villa J, Filella X, Jo J, Farrus B, Giménez N, Traserra J, Ballesta AM. Molina R, et al. Among authors: jo j. Tumour Biol. 1996;17(2):81-9. doi: 10.1159/000217970. Tumour Biol. 1996. PMID: 8658017

10

C-erbB-2 oncoprotein in the sera and tissue of patients with breast cancer. Utility in prognosis.

Molina R, Jo J, Filella X, Zanon G, Pahisa J, Muñoz M, Farrus B, Latre ML, Gimenez N, Hage M, Estape J, Ballesta AM. Molina R, et al. Among authors: jo j. Anticancer Res. 1996 Jul-Aug;16(4B):2295-300. Anticancer Res. 1996. PMID: 8694559

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,050 results

Search Page

Filters